Pharmaceutical News and Articles

PFAS Chemicals May Harm Bones of Hispanic Teens

we are all exposed to them, Chatzi said. We need to eliminate that exposure, to allow our youth to reach their full potential in terms of bone development to he

Some Older Women With Early-Stage Breast Cancer Can Safely Skip Radiotherapy: Study

Women in the their 50s and 60s who ve gone through menopause may be able to safely skip radiation treatment if they re diagnosed with a common form of breast ca

Tennis Ball Impacts Can Also Cause Concussions

a blow to the head powerful enough to disrupt the normal function of the brain.The research team then compared those results with previous research on traumatic

Biden Administration Delays Decision on Menthol Cigarette Ban Amid Pushback

just as President Biden gears up to run for re-election, administration officials told the Washington Post.The delay, which was posted Wednesday, now says offic

Eli Lilly Says Its New Weight-Loss Drug, Zepbound, Is Now Available

Eli Lilly has announced that its newly approved weight-loss medication, Zepbound, is now available for patients to take. Today opens another chapter for adults

Many Patients of Color Expect and Prepare for Unfair Health Care

and nearly double the rate for White patients, the poll showed.Meanwhile, nearly 30 percent of Black respondents said they prepare to be insulted, also about do

Housing Instability Tied to Higher Risk for Dementia Diagnosis

Veterans experiencing housing instability have a substantially higher risk for receiving an Alzheimer disease or related dementia (ADRD) diagnosis versus a matc

Nonagenarians Are Mostly Sedentary, With Low Physical Activity

Nonagenarians are mostly sedentary and report low physical activity, according to a study published online Dec. 6 in PLOS ONE.Sari Aaltonen, Ph.D., from the Uni

Earlier Age at Menarche Raises Type 2 Diabetes Risk

Earlier age at menarche is associated with type 2 diabetes risk among women younger than 65 years, according to a study published online Dec. 5 in BMJ Nutrition

FDA Approves Fabhalta (iptacopan) for the Treatment of Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)